Sheiban Imad, Ge Zhen, Kan Jing, Zhang Jun-Jie, Santoso Teguh, Munawar Muhammad, Ye Fei, Tian Nailiang, Chen Shao-Liang
Division of Cardiology, Pederzoli Hospital-Peschiera del Garda, Verona, Italy.
Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Front Cardiovasc Med. 2022 Oct 11;9:910313. doi: 10.3389/fcvm.2022.910313. eCollection 2022.
Provisional stenting (PS) is the main treatment for a majority of coronary bifurcation lesion and includes PS with 1-stent and PS with 2-stent. However, the treatment difference between PS with 1-stent and with 2-stent remains unclear in patients with the acute coronary syndrome (ACS) and coronary bifurcation lesions.
Overall, 820 ACS patients with Medina 1,1,1 or 0,1,1 coronary bifurcation lesion who had completed 3-year follow-up were included and assigned to the PS with 1-stent (n = 519) or the PS with 2-stent (n = 301) according to the use of final stenting technique. The primary endpoint was the target lesion failure (TLF) at 3 years since stenting procedures.
At 3-year follow-up, TLF occurred in 85 (16.4%) patients in the PS with 1-stent group and 69 (22.9%) in the PS with 2-stent group (hazard ratio [HR] 1.52, 95% confidence interval [CI] 1.06-2.17, p = 0.021), mainly driven by a higher rate of target lesion revascularization (TLR) in the PS with 2-stent group (13.0% vs. 8.3%, HR 1.65, 95% CI 1.04-2.61, p = 0.033). Complex bifurcations, side branch (SB) pretreatment, intravascular imaging guidance, and hyperlipidemia were the four predictors for 3-year TLF. SB pretreatment was associated with increased 3-year TLR, leading to an extremely higher 3-year TLF.
Provisional with 2-stent for patients with ACS is associated with a higher rate of 3-year TLF, mainly due to increased requirement of revascularization. SB pretreatment should be avoided for simple bifurcation lesion.
临时支架置入术(PS)是大多数冠状动脉分叉病变的主要治疗方法,包括单支架PS和双支架PS。然而,在急性冠状动脉综合征(ACS)合并冠状动脉分叉病变的患者中,单支架PS和双支架PS之间的治疗差异仍不明确。
总共纳入820例完成3年随访的Medina 1,1,1或0,1,1型冠状动脉分叉病变的ACS患者,并根据最终支架置入技术的使用情况将其分为单支架PS组(n = 519)或双支架PS组(n = 301)。主要终点是自支架置入术后3年的靶病变失败(TLF)。
在3年随访时,单支架PS组85例(16.4%)患者发生TLF,双支架PS组69例(22.9%)患者发生TLF(风险比[HR] 1.52,95%置信区间[CI] 1.06 - 2.17,p = 0.021),主要原因是双支架PS组的靶病变血运重建(TLR)率较高(13.0%对8.3%,HR 1.65,95% CI 1.04 - 2.61,p = 0.033)。复杂分叉、边支(SB)预处理、血管内成像指导和高脂血症是3年TLF的四个预测因素。SB预处理与3年TLR增加相关,导致3年TLF极高。
ACS患者采用双支架临时置入术与3年TLF发生率较高相关,主要原因是血运重建需求增加。对于简单分叉病变应避免进行SB预处理。